Flow cytometry in clinical cancer research
B Barlogie, MN Raber, J Schumann, TS Johnson… - Cancer research, 1983 - AACR
The prognosis of patients with cancer is largely determined by the specific histological
diagnosis, tumor mass stage, and host performance status. The management of neoplastic …
diagnosis, tumor mass stage, and host performance status. The management of neoplastic …
The taxoids: paclitaxel (TaxolŽ) and docetaxel (TaxotereŽ)
…, JJ Kavanagh, PR Cohen, MN Raber - Cancer treatment …, 1993 - Elsevier
… FA Holmes, RS Walters, RL Theriault, AD Forman, LK Newton, MN Raber, AU … Davilla, JT
Leimert, HM Dhingra, MN Raber, IH Krakoff, WK Hong … Vreeland, MMG Bayssas, MN Raber …
Leimert, HM Dhingra, MN Raber, IH Krakoff, WK Hong … Vreeland, MMG Bayssas, MN Raber …
Cancer of unknown primary site
GR Varadhachary, MN Raber - New England Journal of Medicine, 2014 - Mass Medical Soc
This review summarizes how sophisticated imaging, immunohistochemical testing, and
molecular-profiling tools are changing the approach to cancer of unknown primary site. …
molecular-profiling tools are changing the approach to cancer of unknown primary site. …
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer
…, AD Forman, LK Newton, MN Raber - JNCI: Journal of the …, 1991 - academic.oup.com
Taxol, an antimicrotubule agent, has shown promise for efficacy in treatment of breast
cancer, but severe hypersensitivity reactions led to cessation of many phase I clinical trials. …
cancer, but severe hypersensitivity reactions led to cessation of many phase I clinical trials. …
Metastatic patterns in adenocarcinoma
…, GR Varadhachary, SH Taylor, W Wei, MN Raber… - Cancer, 2006 - Wiley Online Library
BACKGROUND Unique metastatic patterns cited in the literature often arise from anecdotal
clinical observations and autopsy reports. The authors analyzed clinical data from a large …
clinical observations and autopsy reports. The authors analyzed clinical data from a large …
A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.
…, P Tarassoff, W Satterlee, MN Raber - Journal of Clinical …, 1991 - ascopubs.org
A novel deoxycytidine analog, gemcitabine (2',2'-difluorodeoxycytidine [dFdC]), has been
studied in a phase I clinical and pharmacology trial. Doses ranging from 10 to 1,000 mg/m2 …
studied in a phase I clinical and pharmacology trial. Doses ranging from 10 to 1,000 mg/m2 …
Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer
…, J Leimert, H Dhingra, MN Raber… - JNCI: Journal of the …, 1993 - academic.oup.com
Background: Taxol, a complex plant product (a diterpene) extracted from the bark of Taxus
brevifolia, has demonstrated substantial anticancer activity in ovarian and breast cancers, …
brevifolia, has demonstrated substantial anticancer activity in ovarian and breast cancers, …
Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.
…, MC Abbruzzese, KR Hess, MN Raber… - Journal of clinical …, 1994 - ascopubs.org
PURPOSE To evaluate the natural history, validate previous observations, and identify
prognostic factors in patients with unknown primary carcinoma (UPC). PATIENTS AND …
prognostic factors in patients with unknown primary carcinoma (UPC). PATIENTS AND …
Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.
…, R Lenzi, KR Hess, MN Raber - Journal of Clinical …, 1995 - ascopubs.org
PURPOSE Diagnostic strategies designed to identify the underlying primary malignancies
in patients with unknown primary tumors (UPTs) have relied on retrospective analyses. We …
in patients with unknown primary tumors (UPTs) have relied on retrospective analyses. We …
Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma
KR Hess, MC Abbruzzese, R Lenzi, MN Raber… - Clinical Cancer …, 1999 - AACR
The clinical features and survival times of patients with unknown primary carcinoma (UPC)
are heterogeneous. Therefore, the goals of this study were to apply a novel analytical method …
are heterogeneous. Therefore, the goals of this study were to apply a novel analytical method …